KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Novavax (NVAX) Long-Term Debt Issuances (2016)

Novavax (NVAX) has 3 years of Long-Term Debt Issuances data on record, last reported at $325.0 million in Q1 2016.

  • For Q1 2016, Long-Term Debt Issuances changed N/A year-over-year to $325.0 million; the TTM value through Dec 2016 reached $325.0 million, changed N/A, while the annual FY2025 figure was $42.6 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $325.0 million in Q1 2016 per NVAX's latest filing, up from $641000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $325.0 million in Q1 2016 and bottomed at $100000.0 in Q1 2012.
  • Average Long-Term Debt Issuances over 3 years is $65.4 million, with a median of $641000.0 recorded in 2013.
  • The widest YoY moves for Long-Term Debt Issuances: up 709.0% in 2013, down 709.0% in 2013.
  • A 3-year view of Long-Term Debt Issuances shows it stood at $550000.0 in 2012, then rose by 16.55% to $641000.0 in 2013, then skyrocketed by 50602.03% to $325.0 million in 2016.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $325.0 million in Q1 2016, $641000.0 in Q2 2013, and $809000.0 in Q1 2013.